نتایج جستجو برای: acute gvhd

تعداد نتایج: 497927  

2017
Brian C. Betts Joseph Pidala Jongphil Kim Asmita Mishra Taiga Nishihori Lia Perez Jose Leonel Ochoa-Bayona Farhad Khimani Kelly Walton Ryan Bookout Michael Nieder Divis K. Khaira Marco Davila Melissa Alsina Teresa Field Ernesto Ayala Frederick L. Locke Marcie Riches Mohamed Kharfan-Dabaja Hugo Fernandez Claudio Anasetti

Graft-versus-host disease (GvHD) remains a major cause of transplant-related mortality. Interleukin-2 (IL-2) plus sirolimus (SIR) synergistically reduces acute GvHD in rodents and promotes regulatory T cells. This phase II trial tested the hypothesis that IL-2 would facilitate STAT5 phosphorylation in donor T cells, expand regulatory T cells, and ameliorate GvHD. Between 16th April 2014 and 19t...

2016
Young Sok Ji Min Sung Lee Chang Wook Min Seong Kyu Park Se Hyung Kim Jina Yun Hyun Jung Kim Kyoung Ha Kim Chan Kyu Kim Kyu-Taek Lee Jong-Ho Won Dae Sik Hong

BACKGROUND/AIMS There is controversy about the prophylactic effect of anti-thymocyte globulin (ATG) on graft versus host disease (GVHD) in the setting of matched related-donor hematopoietic stem cell transplantation (HSCT). This study assessed the inf luences of ATG on the incidences of acute and chronic GVHD and other clinical outcomes in matched related-donor HSCT. METHODS Sixty-one patient...

Journal: :The Journal of Experimental Medicine 2001
Pavan Reddy Takanori Teshima Mark Kukuruga Rainer Ordemann Chen Liu Kathy Lowler James L.M. Ferrara

Interleukin (IL)-18 is a recently discovered cytokine that modulates both T helper type 1 (Th1) and Th2 responses. IL-18 is elevated during acute graft-versus-host disease (GVHD). We investigated the role of IL-18 in this disorder using a well characterized murine bone marrow transplantation (BMT) model (B6 --> B6D2F1). Surprisingly, blockade of IL-18 accelerated acute GVHD-related mortality. I...

Journal: :Blood 1990
J E Wagner G W Santos S J Noga S D Rowley J Davis G B Vogelsang E R Farmer B A Zehnbauer R Saral A D Donnenberg

In an attempt to reduce the incidence and severity of acute graft-versus-host disease (GVHD), we have decreased the number of bone marrow (BM) lymphocytes in the donor marrow graft before bone marrow transplantation (BMT) using counterflow centrifugal elutriation (CCE). In a phase I-II clinical trial, 23 patients received lymphocyte-depleted BM allografts from their HLA-identical, mixed lymphoc...

1999

Thalidomide has one of the most notorious drug histories because of its teratogenicity. Its widespread use in the 1960s led to a worldwide epidemic of phocomelia in inborns; this in turn led to its complete ban in most of the world. However, it has now been licensed for selected indications including graft-versushost-disease (GVHD) after bone marrow transplantation, wasting associated with tube...

Journal: :Blood 1999
N Tsukada T Kobata Y Aizawa H Yagita K Okumura

Allogeneic bone marrow transplantation (allo-BMT) is associated with both graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) effect. In the present study, we examined the contribution of cytotoxic effector mechanisms, which are mediated by tumor necrosis factor-alpha (TNF-alpha), Fas ligand (FasL), or perforin, to GVHD and GVL effect in a murine BMT model. Bone marrow cells plus s...

Journal: :Blood 2007
Corey Cutler Shuli Li Vincent T Ho John Koreth Edwin Alyea Robert J Soiffer Joseph H Antin

We assessed the combination of sirolimus and tacrolimus without methotrexate after myeloablative allogeneic stem cell transplantation from 53 matched related donors (MRDs) and 30 unrelated donors (URDs). All patients received cyclophosphamide and total body irradiation conditioning followed by transplantation of mobilized peripheral blood stem cells. The median time to neutrophil engraftment wa...

2006
Matthew P. Collin Derek N.J. Hart Graham H. Jackson Gordon Cook James Cavet Stephen Mackinnon Peter G. Middleton Anne M. Dickinson

JEM © The Rockefeller University Press $8.00 Vol. 203, No. 1, January 23, 2006 27–33 www.jem.org/cgi/doi/10.1084/jem.20051787 27 Graft versus host disease (GVHD) is an immune reaction of donor lymphoid cells to antigens expressed by recipients of hematopoietic stem cell transplantation (HSCT). In the acute form, occurring within 100 d after transplant, GVHD is a signifi cant cause of transplant...

Journal: :Blood 2006
Vanessa Rowe Tatjana Banovic Kelli P MacDonald Rachel Kuns Alistair L Don Edward S Morris Angela C Burman Helen M Bofinger Andrew D Clouston Geoffrey R Hill

Host antigen-presenting cells (APCs) are known to be critical for the induction of graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation (BMT), but the relative contribution of specific APC subsets remains unclear. We have studied the role of host B cells in GVHD by using B-cell-deficient microMT mice as BMT recipients in a model of CD4-dependent GVHD to major histocompa...

Journal: :International immunology 2002
Diana Arnold Christoph Wasem Pierre Juillard Pierre Graber Igor Cima Corina Frutschi Simon Herren Sabine Jakob Sami Alouani Christoph Mueller Yolande Chvatchko Thomas Brunner

Acute graft-versus-host disease (GvHD) is a serious complication after allogeneic bone marrow transplantation. Donor-derived T cells infiltrate recipient target organs and cause severe tissue damage, often leading to death of the affected patient. Tissue destruction is a direct result of donor CD8+ T cell activation and cell-mediated cytotoxicity. IL-18 is a novel pro-inflammatory cytokine with...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید